| MODE | 3-methoxy-O-demethyl encainide |
|---|---|
| ODE | O-demethyl encainide |
| encainide | <chemical> (+-)-4-methoxy-n-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)- benzamide. An effective and generally well-tolerated anti-arrhythmia agent for suppressing all forms of ventricular arrhythmia. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, encainide exacerbates the arrhythmia and is not recommended for use in these patients. The drug is a potent blocker of sodium channels and produces marked slowing of conduction within the his-purkinje system and myocardium. Pharmacological action: anti-arrhythmia agents. Chemical name: Benzamide, 4-methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)-, (+-)- (12 Dec 1998) |
|---|---|
| encainide hydrochloride | Benzamide, 4-methoxy-N-[2-[2-(1-methyl-2-piperidinyl)ethyl]phenyl]-, monohydrochloride, (±)-;an anti-arrhythmic. (05 Mar 2000) |
Synonyms : Bristol-Myers Squibb Brand of Encainide Hydrochloride, Encainide Hydrochloride, Encainide Hydrochloride, (+-)-Isomer, Encainide, (+)-Isomer, Encainide, (-)-Isomer, Enkaid, MJ-9067, Bristol Myers Squibb Brand of Encainide Hydrochloride, MJ 9067, MJ9067
| encainide hydrochloride |
(en
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
| encainide | antiarrhythmic drug (trade name Enkaid) used to treat life-threatening arrhythmias but increases the risk of sudden death in heart attack patients |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|